Merck Downplayed Vioxx Risks, Doctor Testifies

Law360, New York (November 29, 2006, 12:00 AM EST) -- Merck & Co. told its salespeople not to tell doctors about a study by a Harvard Medical School professor that found that Vioxx increased the risk of heart attacks, a researcher testified Tuesday in a trial in New Orleans.

“I can think of no legitimate reason why it would ever be appropriate to suppress negative findings about a drug risk,” Dr. Jerome Avorn said on a tape played for jurors in federal court in New Orleans.

The videotape was played for jurors in the trial of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.